Cargando…

Osteoclast-mediated bone loss observed in a COVID-19 mouse model

The consequences of SARS-CoV-2 infection on the musculoskeletal system represent a dangerous knowledge gap. Aging patients are at added risk for SARS-CoV-2 infection; therefore, a greater understanding of the resulting musculoskeletal sequelae of SARS-CoV-2 infection may help guide clinical strategi...

Descripción completa

Detalles Bibliográficos
Autores principales: Awosanya, Olatundun D., Dalloul, Christopher E., Blosser, Rachel J., Dadwal, Ushashi C., Carozza, Mariel, Boschen, Karen, Klemsz, Michael J., Johnston, Nancy A., Bruzzaniti, Angela, Robinson, Christopher M., Srour, Edward F., Kacena, Melissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486589/
https://www.ncbi.nlm.nih.gov/pubmed/34607050
http://dx.doi.org/10.1016/j.bone.2021.116227
_version_ 1784577776598122496
author Awosanya, Olatundun D.
Dalloul, Christopher E.
Blosser, Rachel J.
Dadwal, Ushashi C.
Carozza, Mariel
Boschen, Karen
Klemsz, Michael J.
Johnston, Nancy A.
Bruzzaniti, Angela
Robinson, Christopher M.
Srour, Edward F.
Kacena, Melissa A.
author_facet Awosanya, Olatundun D.
Dalloul, Christopher E.
Blosser, Rachel J.
Dadwal, Ushashi C.
Carozza, Mariel
Boschen, Karen
Klemsz, Michael J.
Johnston, Nancy A.
Bruzzaniti, Angela
Robinson, Christopher M.
Srour, Edward F.
Kacena, Melissa A.
author_sort Awosanya, Olatundun D.
collection PubMed
description The consequences of SARS-CoV-2 infection on the musculoskeletal system represent a dangerous knowledge gap. Aging patients are at added risk for SARS-CoV-2 infection; therefore, a greater understanding of the resulting musculoskeletal sequelae of SARS-CoV-2 infection may help guide clinical strategies. This study examined fundamental bone parameters among mice treated with escalating viral loads. Male C57BL/6J (WT, n = 17) and B6.Cg-Tg(K18-ACE2)2Prlmn/J mice (K18-hACE2 transgenic mice, n = 21) expressing human ACE2 (TG) were divided into eight groups (n = 4–6/group) and subjected to intranasal dosing of 0, 1 × 10(3), 1 × 10(4), and 1 × 10(5) PFU (plaque forming units) of human SARS-CoV-2. Animal health was assessed daily by veterinary staff using established and validated scoring criteria (activity, posture, body condition scores and body weight). We report here that mock and WT infected mice were healthy and completed the study, surviving until 12–14 days post infection (dpi). In contrast, the TG mice infected with 1 × 10(5) PFU all experienced severe health declines that necessitated early euthanasia (6–7 dpi). For TG mice infected with 1 × 10(4) PFU, 2 mice were also euthanized after 7 dpi, while 3 mice showed signs of moderate disease at day 6 dpi, but recovered fully by day 11 dpi. Four of the 5 TG mice that were infected with 1 × 10(3) PFU remained healthy throughout the study. This suggests that our study mimics what is seen during human disease, where some patients develop severe disease resulting in death, while others have moderate to severe disease but recover, and others are asymptomatic. At necropsy, femurs were extracted and analyzed by μCT. No difference was found in μCT determined bone parameters among the WT groups. There was, however, a significant 24.4% decrease in trabecular bone volume fraction (p = 0.0009), 19.0% decrease in trabecular number (p = 0.004), 6.2% decrease in trabecular thickness (p = 0.04), and a 9.8% increase in trabecular separation (p = 0.04) among surviving TG mice receiving any viral load compared to non-infected controls. No differences in cortical bone parameters were detected. TRAP staining revealed surviving infected mice had a significant 64% increase in osteoclast number, a 27% increase in osteoclast surface, and a 38% increase in osteoclasts per bone surface. While more studies are needed to investigate the long-term consequences of SARS-CoV-2 infection on skeletal health, this study demonstrates a significant reduction in several bone parameters and corresponding robust increases in osteoclast number observed within 2 weeks post-infection in surviving asymptomatic and moderately affected mice.
format Online
Article
Text
id pubmed-8486589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84865892021-10-04 Osteoclast-mediated bone loss observed in a COVID-19 mouse model Awosanya, Olatundun D. Dalloul, Christopher E. Blosser, Rachel J. Dadwal, Ushashi C. Carozza, Mariel Boschen, Karen Klemsz, Michael J. Johnston, Nancy A. Bruzzaniti, Angela Robinson, Christopher M. Srour, Edward F. Kacena, Melissa A. Bone Article The consequences of SARS-CoV-2 infection on the musculoskeletal system represent a dangerous knowledge gap. Aging patients are at added risk for SARS-CoV-2 infection; therefore, a greater understanding of the resulting musculoskeletal sequelae of SARS-CoV-2 infection may help guide clinical strategies. This study examined fundamental bone parameters among mice treated with escalating viral loads. Male C57BL/6J (WT, n = 17) and B6.Cg-Tg(K18-ACE2)2Prlmn/J mice (K18-hACE2 transgenic mice, n = 21) expressing human ACE2 (TG) were divided into eight groups (n = 4–6/group) and subjected to intranasal dosing of 0, 1 × 10(3), 1 × 10(4), and 1 × 10(5) PFU (plaque forming units) of human SARS-CoV-2. Animal health was assessed daily by veterinary staff using established and validated scoring criteria (activity, posture, body condition scores and body weight). We report here that mock and WT infected mice were healthy and completed the study, surviving until 12–14 days post infection (dpi). In contrast, the TG mice infected with 1 × 10(5) PFU all experienced severe health declines that necessitated early euthanasia (6–7 dpi). For TG mice infected with 1 × 10(4) PFU, 2 mice were also euthanized after 7 dpi, while 3 mice showed signs of moderate disease at day 6 dpi, but recovered fully by day 11 dpi. Four of the 5 TG mice that were infected with 1 × 10(3) PFU remained healthy throughout the study. This suggests that our study mimics what is seen during human disease, where some patients develop severe disease resulting in death, while others have moderate to severe disease but recover, and others are asymptomatic. At necropsy, femurs were extracted and analyzed by μCT. No difference was found in μCT determined bone parameters among the WT groups. There was, however, a significant 24.4% decrease in trabecular bone volume fraction (p = 0.0009), 19.0% decrease in trabecular number (p = 0.004), 6.2% decrease in trabecular thickness (p = 0.04), and a 9.8% increase in trabecular separation (p = 0.04) among surviving TG mice receiving any viral load compared to non-infected controls. No differences in cortical bone parameters were detected. TRAP staining revealed surviving infected mice had a significant 64% increase in osteoclast number, a 27% increase in osteoclast surface, and a 38% increase in osteoclasts per bone surface. While more studies are needed to investigate the long-term consequences of SARS-CoV-2 infection on skeletal health, this study demonstrates a significant reduction in several bone parameters and corresponding robust increases in osteoclast number observed within 2 weeks post-infection in surviving asymptomatic and moderately affected mice. Elsevier Inc. 2022-01 2021-10-02 /pmc/articles/PMC8486589/ /pubmed/34607050 http://dx.doi.org/10.1016/j.bone.2021.116227 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Awosanya, Olatundun D.
Dalloul, Christopher E.
Blosser, Rachel J.
Dadwal, Ushashi C.
Carozza, Mariel
Boschen, Karen
Klemsz, Michael J.
Johnston, Nancy A.
Bruzzaniti, Angela
Robinson, Christopher M.
Srour, Edward F.
Kacena, Melissa A.
Osteoclast-mediated bone loss observed in a COVID-19 mouse model
title Osteoclast-mediated bone loss observed in a COVID-19 mouse model
title_full Osteoclast-mediated bone loss observed in a COVID-19 mouse model
title_fullStr Osteoclast-mediated bone loss observed in a COVID-19 mouse model
title_full_unstemmed Osteoclast-mediated bone loss observed in a COVID-19 mouse model
title_short Osteoclast-mediated bone loss observed in a COVID-19 mouse model
title_sort osteoclast-mediated bone loss observed in a covid-19 mouse model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486589/
https://www.ncbi.nlm.nih.gov/pubmed/34607050
http://dx.doi.org/10.1016/j.bone.2021.116227
work_keys_str_mv AT awosanyaolatundund osteoclastmediatedbonelossobservedinacovid19mousemodel
AT dalloulchristophere osteoclastmediatedbonelossobservedinacovid19mousemodel
AT blosserrachelj osteoclastmediatedbonelossobservedinacovid19mousemodel
AT dadwalushashic osteoclastmediatedbonelossobservedinacovid19mousemodel
AT carozzamariel osteoclastmediatedbonelossobservedinacovid19mousemodel
AT boschenkaren osteoclastmediatedbonelossobservedinacovid19mousemodel
AT klemszmichaelj osteoclastmediatedbonelossobservedinacovid19mousemodel
AT johnstonnancya osteoclastmediatedbonelossobservedinacovid19mousemodel
AT bruzzanitiangela osteoclastmediatedbonelossobservedinacovid19mousemodel
AT robinsonchristopherm osteoclastmediatedbonelossobservedinacovid19mousemodel
AT srouredwardf osteoclastmediatedbonelossobservedinacovid19mousemodel
AT kacenamelissaa osteoclastmediatedbonelossobservedinacovid19mousemodel